These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20216164)

  • 1. The role of calcium channel blockers, steroids, anticoagulation, antiplatelet drugs, and endothelin receptor antagonists.
    Adatia I; Shekerdemian L
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S46-52. PubMed ID: 20216164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for pulmonary arterial hypertension.
    Liu C; Liu K; Ji Z; Liu G
    Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapeutic management of pulmonary arterial hypertension.
    Anderson JR; Nawarskas JJ
    Cardiol Rev; 2010; 18(3):148-62. PubMed ID: 20395700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary pulmonary hypertension: new treatment options].
    Madan S; Boonstra A; Berger RM
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1836-42. PubMed ID: 11593786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary arterial hypertension. Part II: Medical and surgical treatment].
    Manes A; Marinelli A; Palazzini M; Negro L; Leci E; Gambetti S; Bachetti C; Beciani E; Conficoni E; Branzi A; Galiè N
    G Ital Cardiol (Rome); 2009 Jun; 10(6):366-81. PubMed ID: 19603608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary pulmonary hypertension and its management].
    Crespo Martínez C; Morales León V; Alonso Ramos H; Alonso Ortiz B; Molero Gómez R
    Farm Hosp; 2004; 28(1):48-55. PubMed ID: 15012178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute circulatory failure caused by primary pulmonary hypertension or pulmonary embolism].
    Meyer G; Sanchez O
    Rev Mal Respir; 2000 Feb; 17(1):51-65. PubMed ID: 10756556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment strategies for pulmonary arterial hypertension.
    Lee SH; Rubin LJ
    J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin receptor antagonists in pulmonary arterial hypertension.
    Channick RN; Sitbon O; Barst RJ; Manes A; Rubin LJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):62S-67S. PubMed ID: 15194180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension: an update on diagnosis and treatment.
    Stringham R; Shah NR
    Am Fam Physician; 2010 Aug; 82(4):370-7. PubMed ID: 20704168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapeutics and practical management strategies for pulmonary arterial hypertension.
    Agarwal R; Gomberg-Maitland M
    Am Heart J; 2011 Aug; 162(2):201-13. PubMed ID: 21835279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the treatment of pediatric pulmonary artery hypertension.
    Barst RJ
    Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current views on the use of vasodilators in pulmonary hypertension].
    Ceriana P; De Amici D; Pagnin A; Braschi A
    Minerva Cardioangiol; 1995 Jun; 43(6):273-9. PubMed ID: 7566540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.
    Rich S; Kaufmann E; Levy PS
    N Engl J Med; 1992 Jul; 327(2):76-81. PubMed ID: 1603139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure].
    Ghofrani HA; Olschewski H; Seeger W; Grimminger F
    Pneumologie; 2002 Nov; 56(11):665-72. PubMed ID: 12442206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endothelium pharmacology in pulmonary hypertension].
    Fedorowicz A; Chłopicki S
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S462-71. PubMed ID: 20527402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.